Journal article
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
Anastasia Chrysostomou, Eugenia Pedagogos, Lachlan MacGregor, Gavin J Becker
Clinical Journal of the American Society of Nephrology | AMER SOC NEPHROLOGY | Published : 2006
DOI: 10.2215/CJN.01040905